Nu-Metoclopramide en es it fr

Nu-Metoclopramide Brand names, Nu-Metoclopramide Analogs

Nu-Metoclopramide Brand Names Mixture

  • No information avaliable

Nu-Metoclopramide Chemical_Formula


Nu-Metoclopramide RX_link

Nu-Metoclopramide fda sheet

Nu-Metoclopramide FDA

Nu-Metoclopramide msds (material safety sheet)

Nu-Metoclopramide MSDS

Nu-Metoclopramide Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Nu-Metoclopramide Molecular Weight

299.796 g/mol

Nu-Metoclopramide Melting Point

147.25 oC

Nu-Metoclopramide H2O Solubility

200 mg/L

Nu-Metoclopramide State


Nu-Metoclopramide LogP


Nu-Metoclopramide Dosage Forms

Liquid; Syrup; Tablet

Nu-Metoclopramide Indication

For the treatment of gastroesophageal reflux disease (GERD)

Nu-Metoclopramide Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Nu-Metoclopramide Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Nu-Metoclopramide side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Nu-Metoclopramide Patient Information

Nu-Metoclopramide Organisms Affected

Humans and other mammals